Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Batavia Biosciences
Batavia Biosciences
Activities:
Manufacturing
Regulatory
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Overcoming CMC challenges in cell and gene therapy: part II
Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC...
SNIPR Biome receives funding to progress CRISPR medicine SNIPR001 into clinical trials
Phase 1b/2a trial will evaluate SNIPR001 for the prevention of E.coli infections in patients undergoing hematopoietic stem cell transplantation
Kindeva Drug Delivery appoints Denis Johnson as Chief Operating Officer
Denis will be responsible for optimising global operations for the company
SeaBeLife awarded over €1.5 million in i-Nov innovation competition
Funding for company’s SeaBeEYE project will be used to develop a new therapeutic approach for geographic atrophy, a form of age-related macular degeneration
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Manufacturing
Batavia enters the commercial manufacturing business
Batavia Biosciences is set to extend its CDMO services portfolio (R&D and clinical manufacturing) to include commercial manufacturing services
Manufacturing
Global alliance chooses Horizon Discovery cell line for Zika antibody
Batavia Biosciences, Vanderbilt University Medical Center (VUMC) and IDBiologics will use the cell line expression system to produce and antibody for the potent virus
Pharmaceutical
Univercells launches new vaccine manufacturing platform
Low-cost vaccine manufacturing technology, NevoLine, has been launched and already received grant for scale-up
Research & Development
Batavia partners with IAVI to advance development of vaccine against Lassa fever
The International AIDS Vaccine Initiative (IAVI) and Batavia Biosciences will work together under a grant to advance the development of a Lassa fever vaccine
Research & Development
Batavia Biosciences receives $8 million grant to develop rotavirus vaccine
Will develop a low-cost manufacturing process using novel technologies in partnership with Bio Farma
Subscribe now